Puma Biotechnology Inc (PBYI)
4.88
+0.05
(+1.04%)
USD |
NASDAQ |
Apr 25, 16:00
4.88
0.00 (0.00%)
Pre-Market: 09:16
Puma Biotechnology Market Cap: 235.25M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 25, 2024 | 235.25M |
April 24, 2024 | 232.84M |
April 23, 2024 | 247.30M |
April 22, 2024 | 249.23M |
April 19, 2024 | 241.52M |
April 18, 2024 | 240.55M |
April 17, 2024 | 249.23M |
April 16, 2024 | 245.86M |
April 15, 2024 | 257.91M |
April 12, 2024 | 254.05M |
April 11, 2024 | 264.66M |
April 10, 2024 | 266.34M |
April 09, 2024 | 281.05M |
April 08, 2024 | 271.41M |
April 05, 2024 | 272.85M |
April 04, 2024 | 265.62M |
April 03, 2024 | 257.91M |
April 02, 2024 | 254.53M |
April 01, 2024 | 254.53M |
March 28, 2024 | 255.50M |
March 27, 2024 | 269.00M |
March 26, 2024 | 269.96M |
March 25, 2024 | 269.48M |
March 22, 2024 | 256.94M |
March 21, 2024 | 257.91M |
Date | Value |
---|---|
March 20, 2024 | 226.33M |
March 19, 2024 | 207.29M |
March 18, 2024 | 224.65M |
March 15, 2024 | 241.04M |
March 14, 2024 | 251.64M |
March 13, 2024 | 256.94M |
March 12, 2024 | 257.91M |
March 11, 2024 | 264.66M |
March 08, 2024 | 257.91M |
March 07, 2024 | 277.19M |
March 06, 2024 | 266.59M |
March 05, 2024 | 249.71M |
March 04, 2024 | 258.39M |
March 01, 2024 | 283.94M |
February 29, 2024 | 299.85M |
February 28, 2024 | 318.17M |
February 27, 2024 | 311.42M |
February 26, 2024 | 312.38M |
February 23, 2024 | 312.09M |
February 22, 2024 | 281.59M |
February 21, 2024 | 310.18M |
February 20, 2024 | 323.52M |
February 16, 2024 | 338.77M |
February 15, 2024 | 333.05M |
February 14, 2024 | 352.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
73.76M
Minimum
May 11 2022
1.289B
Maximum
Apr 26 2019
283.71M
Average
266.34M
Median
Apr 10 2024
Market Cap Benchmarks
ADMA Biologics Inc | 1.470B |
Regeneron Pharmaceuticals Inc | 97.76B |
Sarepta Therapeutics Inc | 11.96B |
CytomX Therapeutics Inc | 108.35M |
Mirum Pharmaceuticals Inc | 1.151B |
Market Cap Related Metrics
PE Ratio | 10.84 |
PS Ratio | 0.9847 |
Price to Book Value | 4.402 |
Price to Free Cash Flow | 16.15 |
Price | 4.88 |
Earnings Yield | 9.22% |
Operating PE Ratio | 6.975 |
Normalized PE Ratio | 10.55 |